CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is a leading peer-reviewed journal published by Wiley, renowned for its commitment to advancing the field of ophthalmology. With an impressive impact factor reflecting its high-quality research contributions, this journal is ranked in the Q1 category both in Medicine (miscellaneous) and Ophthalmology, signifying its crucial role in shaping contemporary ophthalmic research. It boasts a remarkable position in the Scopus Ranks, standing at Rank #13 out of 137 in the field of Medicine and Ophthalmology, placing it within the 90th percentile among its peers. Having been in circulation since 1979, this journal encompasses a broad scope of topics that aim to disseminate groundbreaking findings and stimulate dialogue among researchers, clinicians, and students alike. It is easily accessible to a global audience, embodying the principles of open access, making valuable research available to all. For anyone seeking to stay at the forefront of ophthalmology, CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY is an indispensable resource that fosters knowledge and innovation in the ever-evolving landscape of eye care.

The International Journal of Ophthalmology, with ISSN 2222-3959 and E-ISSN 2227-4898, is a premier open-access publication dedicated to advancing the field of ophthalmology. Published by IJO PRESS in China, this journal has been a valuable resource since its inception in 2005, providing a platform for groundbreaking research and clinical studies in ophthalmic science. With an impressive Q2 ranking in the 2023 Ophthalmology category and a Scopus rank of #65 out of 137, the journal consistently showcases high-quality articles that contribute significantly to the understanding and treatment of eye diseases. Since adopting an open-access model in 2010, it has expanded its reach, allowing researchers, professionals, and students worldwide to access vital knowledge in the field. The journal aims to bridge the gap between laboratory research and clinical practice, making it an essential resource for those committed to improving visual health and advancing ophthalmologic education and innovation.

Ophthalmologie is a distinguished journal published by Springer Heidelberg, specializing in the broad and evolving field of ophthalmology. With an ISSN of 2731-720X and an E-ISSN of 2731-7218, the journal serves as a pivotal platform for disseminating cutting-edge research and clinical advancements in the realm of eye health. As of 2023, it ranks in the third quartile (Q3) within both the general medicine and ophthalmology categories, reflecting its substantial contribution to the academic community and the field's knowledge base. The journal aims to foster collaboration among researchers, medical professionals, and students by offering innovative findings that enhance understanding and treatment of ocular diseases. By nurturing high-quality scholarly discussions, Ophthalmologie plays an essential role in the ongoing development of therapeutic strategies and ophthalmic techniques that ultimately benefit patient care globally. This commitment to excellence is evident as it continues to evolve through its convergence from 1992 to 2023, staying relevant in an ever-changing scientific environment.

ACTA OPHTHALMOLOGICA, published by Wiley, is a premier academic journal dedicated to advancing the field of ophthalmology and related medical disciplines. Established in 1923 and maintaining esteemed status through converged years until 1994, and then from 2008 to the present, this journal has consistently delivered pioneering research, reviews, and clinical advancements essential for both practitioners and researchers in eye care. With an impressive impact factor and ranking within the top 15 of its category, ACTA OPHTHALMOLOGICA stands as a Q1 journal in both Medicine (Miscellaneous) and Ophthalmology, reflecting its significant contribution to the field. Although it is not an open-access journal, it continues to offer valuable insights and empirical findings that inform clinical practices and innovative research approaches. As such, it remains a vital resource for scholars, clinicians, and students keen to stay at the forefront of ophthalmological science.

RETINA - THE JOURNAL OF RETINAL AND VITREOUS DISEASES is a premier peer-reviewed journal dedicated to advancing the knowledge and practice of retinal and vitreous disorders. Published by LIPPINCOTT WILLIAMS & WILKINS, this esteemed journal boasts a significant impact factor, affirming its standing in the academic community. With a long history of publication since 1981, its scope covers cutting-edge research and innovations aimed at improving patient outcomes in ophthalmology. As evidenced by its recent categorization in the Q1 quartile for both Medicine (miscellaneous) and Ophthalmology in 2023, the journal ranks impressively, placing it in the 84th percentile among its peers. Researchers, clinicians, and students will find valuable insights and evidence-based articles that contribute to the ever-evolving landscape of retinal health. RETINA remains committed to fostering an environment for scholarly dialogue and dissemination of knowledge, ensuring its readers are at the forefront of advancements in their field.

Saudi Journal of Ophthalmology, published by Wolters Kluwer Medknow Publications, stands as a crucial platform for the dissemination of innovative research and clinical practices in the field of ophthalmology. Since its inception in 2009, this journal has effectively contributed to the growing body of knowledge with a focus on addressing the diverse visual health challenges faced globally. With an ISSN of 1319-4534 and a E-ISSN of 2542-6680, the journal is indexed in Scopus, where it ranks in the Q3 category of ophthalmology, reflecting its commitment to quality research despite the competitive landscape. Situated in India, it provides a unique regional perspective while facilitating global discourse among researchers, practitioners, and students in ophthalmological sciences. Although it currently does not operate as an open-access journal, the Saudi Journal of Ophthalmology is essential for those aiming to expand their understanding of advancements in eye care, making it a valuable resource for professionals dedicated to enhancing patient outcomes through informed research and clinical practice.

The International Journal of Retina and Vitreous, published by BMC, stands as a premier open-access platform dedicated to advancing the field of ophthalmology, specifically focusing on retina and vitreous research. Established in 2015, this journal has swiftly positioned itself within the academic community, achieving a commendable Q2 category ranking in Ophthalmology for 2023, and ranks #49 out of 137 in Scopus for Medicine - Ophthalmology, indicating its growing influence and reach within the scientific landscape. The journal is committed to disseminating high-quality research, reviews, and clinical insights that explore innovations, challenges, and breakthroughs in ocular health. With the goal of fostering knowledge exchange among researchers, practitioners, and students, the International Journal of Retina and Vitreous promotes an open-access model, ensuring that vital findings are readily available to a global audience. This journal not only serves as a vital resource for advancing the understanding and treatment of retinal and vitreous diseases but also aims to inspire future studies in this critical area of eye health.

Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

OPHTHALMOLOGICA is a prestigious journal published by KARGER, dedicated to the dynamic field of ophthalmology and its interdisciplinary connections with medicine and sensory systems. With a rich history spanning over a century since its inception in 1899, this journal is esteemed for its high-quality research and impactful contributions, maintaining an impressive Q1 quartile ranking in both ophthalmology and miscellaneous medicine as of 2023, alongside a notable Q2 status in sensory systems. The journal's influence is reinforced by its Scopus rankings, where it ranks 26th out of 137 in ophthalmology, showcasing a strong percentile position of 81. Based in Basel, Switzerland, OPHTHALMOLOGICA serves as an essential platform for researchers, professionals, and students, providing essential insights, reviews, and studies that push the boundaries of knowledge in the vision sciences. Although it does not currently offer open access, its contributions are critical for those pursuing advancements in ocular health and related disciplines.

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.